Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
IPCA-Enalapril Enalapril maleate 5mg Tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Silvassa, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
IPCA-Enalapril Enalapril maleate 10mg Tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Silvassa, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
IPCA-Enalapril Enalapril maleate 20mg Tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Silvassa, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
IPCA-Enalapril Alemtuzumab 10mg/mL Concentrate for infusion Sanofi-Aventis New Zealand Limited Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
|
Dated this 31st day of May 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).